I have spent the majority of my 15 year career in the Life Sciences industry working with hundreds of public and private corporations as a healthcare investment banker with Citigroup and Deutsche Bank. From Analyst through Managing Director, I led 40 financing and M&A deals, totaling $35 billion in deal value, and learned many invaluable lessons working with clients across the drug, diagnostic, and device spectrum, such as Amgen, Anacor, Eli Lilly, Fosun, Masimo, Medtronic, Pacific Biosciences, Shanghai Pharma, and many others. I began my career as a bioengineer at Life Technologies. I graduated with a M.S.E. in Bioengineering from the University of Pennsylvania and a B.S.E. in Bioengineering with a focus in Computer Science from the University of California at Berkeley. After many years of academic and professional experience in the healthcare field, a deeply personal experience later in life gave me a new perspective into how much healthcare needed to change – my mother was abruptly diagnosed with stage IVb cancer. This compelled me to ask “where were all the signs†and “isn`t there a better way,†which led to BioTrillion.
©